These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23672694)

  • 1. Primary cutaneous CD4 positive small/medium T-cell lymphoma with high proliferation index and CD30-positive large lymphoid cells.
    Zhang L; Shao H
    J Cutan Pathol; 2013 Aug; 40(8):720-4. PubMed ID: 23672694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD30+ T cell enriched primary cutaneous CD4+ small/medium sized pleomorphic T cell lymphoma: A distinct variant of indolent CD4+ T cell lymphoproliferative disease.
    Magro CM; Olson LC; Fulmer CG
    Ann Diagn Pathol; 2017 Oct; 30():52-58. PubMed ID: 28965629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of follicular T-helper cells in primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoma and dermatitis.
    Ally MS; Prasad Hunasehally RY; Rodriguez-Justo M; Martin B; Verdolini R; Attard N; Child F; Attygalle A; Whittaker S; Morris S; Robson A
    J Cutan Pathol; 2013 Dec; 40(12):1006-13. PubMed ID: 24274425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of programmed death-1 in primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma.
    Cetinözman F; Jansen PM; Willemze R
    Am J Surg Pathol; 2012 Jan; 36(1):109-16. PubMed ID: 21989349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pagetoid reticulosis with CD30 positivity and cytotoxic/suppressor cells.
    Jacyk WK; Grayson W; Dinkel JE; Requena L
    J Cutan Pathol; 2007 Aug; 34(8):644-7. PubMed ID: 17640236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary cutaneous small/medium CD4+ T-cell lymphomas: a heterogeneous group of tumors with different clinicopathologic features and outcome.
    Garcia-Herrera A; Colomo L; Camós M; Carreras J; Balague O; Martinez A; Lopéz-Guillermo A; Estrach T; Campo E
    J Clin Oncol; 2008 Jul; 26(20):3364-71. PubMed ID: 18541895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acneiform primary cutaneous CD4-positive small/medium pleomorphic T-cell lymphoma with prominent necrosis.
    Wang L; Wang G; Gao T
    J Cutan Pathol; 2015 Apr; 42(4):265-70. PubMed ID: 25407448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up and management of small and medium-sized CD4
    Virmani P; Jawed S; Myskowski PL; Horwitz S; Skripnik Lucas A; Moskowitz A; Pulitzer M; Zain J; Rosen ST; Querfeld C
    Int J Dermatol; 2016 Nov; 55(11):1248-1254. PubMed ID: 27369070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of CD30+ nasal natural killer/T-cell lymphoma.
    Ferenczi K; Summers P; Aubert P; Cooper B; Meyerson H; Cooper KD; Honda K
    Am J Dermatopathol; 2008 Dec; 30(6):567-71. PubMed ID: 19033930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
    Berti E; Tomasini D; Vermeer MH; Meijer CJ; Alessi E; Willemze R
    Am J Pathol; 1999 Aug; 155(2):483-92. PubMed ID: 10433941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrafacial indolent CD8-positive cutaneous lymphoid proliferation with unusual symmetrical presentation involving both feet.
    Wobser M; Petrella T; Kneitz H; Kerstan A; Goebeler M; Rosenwald A; Geissinger E
    J Cutan Pathol; 2013 Nov; 40(11):955-61. PubMed ID: 24102688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
    Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
    Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cutaneous CD4+ small-/medium-sized pleomorphic T-cell lymphoma: a cutaneous nodular proliferation of pleomorphic T lymphocytes of undetermined significance? A study of 136 cases.
    Beltraminelli H; Leinweber B; Kerl H; Cerroni L
    Am J Dermatopathol; 2009 Jun; 31(4):317-22. PubMed ID: 19461234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indolent CD8-positive T-cell lymphoid proliferation of the ear: a report of two cases.
    Zeng W; Nava VE; Cohen P; Ozdemirli M
    J Cutan Pathol; 2012 Jul; 39(7):696-700. PubMed ID: 22612273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype.
    Kummer JA; Vermeer MH; Dukers D; Meijer CJ; Willemze R
    J Invest Dermatol; 1997 Nov; 109(5):636-40. PubMed ID: 9347791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indolent CD8+ lymphoid proliferation of the ear: report of two cases and review of the literature.
    Swick BL; Baum CL; Venkat AP; Liu V
    J Cutan Pathol; 2011 Feb; 38(2):209-15. PubMed ID: 21083681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification.
    Kong YY; Dai B; Kong JC; Zhou XY; Lu HF; Shen L; Du X; Shi DR
    Am J Surg Pathol; 2008 Oct; 32(10):1495-502. PubMed ID: 18708940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma with a CD15(+)CD30(-) phenotype.
    Yoshizawa N; Yagi H; Horibe T; Takigawa M; Sugiura M
    Eur J Dermatol; 2007; 17(5):441-2. PubMed ID: 17673391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indolent lymphoma of the ear].
    Valois A; Bastien C; Granel-Broca F; Cuny JF; Barbaud A; Schmutz JL
    Ann Dermatol Venereol; 2012 Dec; 139(12):818-23. PubMed ID: 23237280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoma: temporary remission by oral doxycycline.
    Toberer F; Hartschuh W; Hadaschik E
    JAMA Dermatol; 2013 Aug; 149(8):956-9. PubMed ID: 23760549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.